Abstract
Essential tremor (ET) is a common neurological condition that is clinically diagnosed. Although several specific criteria exist, all require the presence of postural or action tremor in the arms without any other neurological conditions to account for such a tremor. Action tremor is identified in any scenario when those muscles are volitionally used. In contrast, rest tremor, which is characteristic for Parkinson’s disease, occurs when the muscles are not volitionally engaged. For example, rest tremor may occur when the arms are resting on the patient’s legs or when dangling while walking, while arm action tremor may occur when the patient is holding the arms in front (postural tremor) or moving the hand back and forth between two points (kinetic tremor). Intention tremor is also seen when moving between two points; however, the amplitude increases when approaching the targeted points. Intention tremor is usually seen in cerebellar pathology, such as multiple sclerosis. In short, postural, kinetic and intention tremor are all subsets of action tremor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fung VS, Sauner D, Day BL. A dissociation between subjective and objective unsteadiness in primary orthostatic tremor. Brain 2001; 124:322–330.
Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol 2003; 60:117–121.
Ondo W, Vuong K, Sutton L, Jankovic J. Assessment of hearing loss in essential tremor. Neurology 2001; 58(suppl 3):A433–434.
Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord 1994; 9:193–196.
Louis ED, Vonsattel JP. The emerging neuropathology of essential tremor. Mov Disord 2008; 23:174–182.
Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64:2008–2020.
Bushara KO, Goldstein SR, Grimes GJ Jr, et al. Pilot trial of 1-octanol in essential tremor. Neurology 2004; 62:122–124.
Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006; 66:672–677.
Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699–1706.
Schuurman P, Bosch A, Merkus P. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000; 342:461–468.
Rights and permissions
Copyright information
© 2009 Current Medicine Group, a part of Springer Science+Business Media
About this chapter
Cite this chapter
Ondo, W.G. (2009). Essential Tremor. In: Handbook of Movement Disorders. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-04-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-908517-04-3_4
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-85873-440-8
Online ISBN: 978-1-908517-04-3
eBook Packages: MedicineMedicine (R0)